Industries > Pharma > Drug Discovery Outsourcing Market Report 2022-2032
Back to Pharma Reports
Drug Discovery Outsourcing Market Report 2022-2032

Drug Discovery Outsourcing Market Report 2022-2032

Forecasts by Service Type (Chemical Services, Biology Services, Lead Optimisation, Lead Identification & Screening, Others), by Molecule Type (Large Molecule Drugs, Small Molecule Drugs), by Therapeutic Area (Oncology, Infectious Disease, Central Nervous System, Immunology, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact Analysis and Recovery Pattern Analysis

PUBLISHED: 06 June 2022
PAGES: 355
PRODUCT CODE: PHA1170
SUBMARKET: Drug Discovery Development & Production

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA1170 Categories: , Tags: , ,

The Drug Discovery Outsourcing Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Outsourcing Drug Development Procedures to Benefit the Pharmaceutical Industry
Outsourcing drug development procedures allows scientists to focus on developing and commercialising new and novel methodologies and technologies, as well as other discoveries that could benefit the pharmaceutical industry. Pharmaceutical or biotech companies are looking to obtain significant added value that complements or substitutes internal power, expense, speed and development capabilities. Even small start-up drug research companies sometimes outsource their chemistry from the very beginning of their activities, because their creditors push them to do so, primarily because of cost-effectiveness reasons.

Reduced Pharmaceutical and Biotech R&D Budgets
Pharmaceutical and biotech companies now look to their outsourcing partners to weigh up important strategic and implementation decisions as well. Price, time to market, and risk are leading more businesses to reduce their innovation dependency on internal R&D. It is common practice to outsource R&D and purchase the rights to goods from smaller companies. Pharmaceutical firms are gradually entering into long-term drug development alliances with other pharmaceutical firms, universities and smaller biotech companies. Price, flexibility / scalability and exposure to new / different talent pools are the main drivers for businesses outsourcing diverse R&D functions. Companies traditionally outsourced the different functions to achieve a cost advantage, now more companies are outsourcing to get the best creativity and cooperation with their outsourcing partners. The old model was to outsource one part of the business cycle. The method was provided by outsourcers at less cost and with fair efficiency. R&D companies in life sciences today are looking at outsourcing as an innovation driver not only to bring drugs into the market quicker but also to get the information technology to make better decisions.

Advancement in Biotech Sector Driving the DDOS Market Growth
Over the last decade, a number of traditional in-house drug discovery activities have been rapidly outsourced to an increasingly competitive pharmaceutical industry that seeks to improve efficiency and reduce spending. This is due to advances in genomics and modern biotechnology, all of which have contributed to the explosion of new biological targets and new drug leads. The hit-to-candidate stage is eventually leading to a crucial bottleneck in the drug discovery process. In order to overcome this problem, the once secretive drug discovery process, such as lead identification and screening, is entrusted to drug discovery organizations specializing in areas such as chemistry services, biology services, lead optimisation as well as lead identification and screening. This push by pharmaceutical companies to gain a complete edge while remaining cost effective is the main driver drug discovery outsourcing. The main factor that the drug discovery outsourcing focuses on is the cost-saving benefits. Today’s companies are also looking at benefits and opportunities beyond cost savings. Companies are now outsourcing to obtain strategic benefits, such as access to new technologies or access to developing markets, quicker response time to help and benchmark internal initiatives, and ongoing process improvements, making them more competitive overall and growing globalization within the pharmaceutical industry.

What Are These Questions You Should Ask Before Buying A Market Research Report?
• How is the drug discovery outsourcing market evolving?
• What is driving and restraining the drug discovery outsourcing market?
• How will each Drug Discovery Outsourcing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each Drug Discovery Outsourcing submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading Drug Discovery Outsourcing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Drug Discovery Outsourcing projects for these leading companies?
• How will the industry evolve during the period between 2022 and 2032? What are the implication of Drug Discovery Outsourcing projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the drug discovery outsourcing market?
• Where is the drug discovery outsourcing market heading? And how can you ensure you are at the forefront of the market?
• What can be the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path? C-suite?

You need to discover how this will impact the drug discovery outsourcing market today, and over the next 10 years:
• Our 355-page report provides 122 tables and 150 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• Contains in-depth analyse of global, regional and national sales and growth
• Highlights for you the key successful trends, changes and revenue projections made by your competitors

This report tells you TODAY how the drug discovery outsourcing market will develop in the next 10 years, and in-line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Delivers exclusive COVID-19 variations economic data specific to your market.

To access the data contained in this document please email contactus@visiongain.com

Forecasts to 2032 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Drug Discovery Outsourcing prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, V, L, W and U are discussed in this report.

Segments Covered in the Report

Service Type
• Chemical Services
• Biology Services
• Lead Optimization
• Lead Identification & Screening
• Others

Molecule Type
• Large Molecule Drugs
• Small Molecule Drugs

Therapeutic Area
• Oncology
• Infectious Disease
• Central Nervous System
• Immunology
• Cardiovascular Disease
• Metabolic Disease
• Respiratory Disease
• Others

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

Drug Discovery Outsourcing Market Report 2022-2032
Need industry data? Please contact us today.

The report also includes profiles and for some of the leading companies in the Drug Discovery Outsourcing Market, 2022 to 2032, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Aragen Life Sciences Pvt. Ltd. (GVK Biosciences)
• Charles River Laboratories
• Curia Global, Inc.
• Dalton Pharma
• Domainex
• Eurofins
• Evotec AG
• Genscript
• Jubilant Biosys Ltd.
• Laboratory Corporation of America Holdings
• Pharmaron
• QIAGEN N.V.
• Selvita
• Sundia Meditech Co Ltd.
• Sygnature Discovery
• Syngene International
• Thermo Fisher Scientific Inc.
• WuXi AppTec

Overall world revenue for Drug Discovery Outsourcing Market, 2022 to 2032 in terms of value the market will surpass US$9.8 billion in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Drug Discovery Outsourcing Market, 2022 to 2032 Market report helps you?
In summary, our 350+ page report provides you with the following knowledge:

• Revenue forecasts to 2032 for Drug Discovery Outsourcing Market, 2022 to 2032 Market, with forecasts for Process, upstream, downstream, type company size each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues

• Revenue forecasts to 2032 for 5 regional and 20 key national markets – See forecasts for the Drug Discovery Outsourcing Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market– including company profiles for 18 of the major companies involved in the Drug Discovery Outsourcing Market, 2022 to 2032 Market.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Drug Discovery Outsourcing Market, 2022 to 2032 Market and leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Drug Discovery Outsourcing Market Report 2022-2032: Forecasts by Service Type (Chemical Services, Biology Services, Lead Optimisation, Lead Identification & Screening, Others), by Molecule Type (Large Molecule Drugs, Small Molecule Drugs), by Therapeutic Area (Oncology, Infectious Disease, Central Nervous System, Immunology, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact Analysis and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Drug Discovery Outsourcing Market Report 2022-2032

    Related reports

    Download sample pages

    Complete the form below to download your free sample pages for Drug Discovery Outsourcing Market Report 2022-2032

      Connect with us

      Visiongain Pharma

      Visiongain Pharma

      Visiongain Pharma

      Latest Pharma news

      Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

      The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

      18 April 2024

      READ
      Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

      The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

      17 April 2024

      READ
      Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

      The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

      12 April 2024

      READ
      Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034

      The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.

      11 April 2024

      READ